FR2679139B1 - Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation. - Google Patents

Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.

Info

Publication number
FR2679139B1
FR2679139B1 FR9109017A FR9109017A FR2679139B1 FR 2679139 B1 FR2679139 B1 FR 2679139B1 FR 9109017 A FR9109017 A FR 9109017A FR 9109017 A FR9109017 A FR 9109017A FR 2679139 B1 FR2679139 B1 FR 2679139B1
Authority
FR
France
Prior art keywords
androstenic
derivative
preparation
pharmaceutical compositions
novel pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9109017A
Other languages
English (en)
Other versions
FR2679139A1 (fr
Inventor
Gerard Schwadrohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9109017A priority Critical patent/FR2679139B1/fr
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Priority to PCT/FR1992/000549 priority patent/WO1992022300A1/fr
Priority to AT92912769T priority patent/ATE185071T1/de
Priority to JP50077393A priority patent/JP3328729B2/ja
Priority to DK92912769T priority patent/DK0593520T3/da
Priority to EP92912769A priority patent/EP0593520B1/fr
Priority to DE69230069T priority patent/DE69230069T2/de
Priority to ES92912769T priority patent/ES2139602T3/es
Priority to CA002111699A priority patent/CA2111699A1/fr
Priority to KR1019930703965A priority patent/KR100249555B1/ko
Priority to US08/170,179 priority patent/US5506220A/en
Priority to IE922252A priority patent/IE922252A1/en
Priority to DZ920090A priority patent/DZ1600A1/fr
Priority to MA22876A priority patent/MA22592A1/fr
Priority to TNSN92063 priority patent/TNSN92063A1/fr
Publication of FR2679139A1 publication Critical patent/FR2679139A1/fr
Application granted granted Critical
Publication of FR2679139B1 publication Critical patent/FR2679139B1/fr
Priority to GR990403060T priority patent/GR3031967T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9109017A 1991-06-18 1991-07-17 Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation. Expired - Fee Related FR2679139B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR9109017A FR2679139B1 (fr) 1991-07-17 1991-07-17 Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.
US08/170,179 US5506220A (en) 1991-06-18 1992-06-18 Anti-glaucomatous pharmaceutical composition and the process for obtaining them
JP50077393A JP3328729B2 (ja) 1991-06-18 1992-06-18 抗緑内障薬剤組成物
DK92912769T DK0593520T3 (da) 1991-06-18 1992-06-18 Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom
EP92912769A EP0593520B1 (fr) 1991-06-18 1992-06-18 Compositions oculaires contenant des steroides et leur utilisation pour le traitement du glaucome
DE69230069T DE69230069T2 (de) 1991-06-18 1992-06-18 Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
ES92912769T ES2139602T3 (es) 1991-06-18 1992-06-18 Composiciones oculares que contienen esteroides y su utilizacion para el tratamiento del glaucoma.
CA002111699A CA2111699A1 (fr) 1991-06-18 1992-06-18 Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention
PCT/FR1992/000549 WO1992022300A1 (fr) 1991-06-18 1992-06-18 Compositions oculaires contenant des steroïdes et leur utilisation pour le traitement du glaucome
AT92912769T ATE185071T1 (de) 1991-06-18 1992-06-18 Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
KR1019930703965A KR100249555B1 (ko) 1991-06-18 1992-06-18 스테로이드를 함유하는 안구용 조성물, 및 녹내장 치료에 이들 조성물을 사용하는 방법
IE922252A IE922252A1 (en) 1991-07-17 1992-07-10 Anti-glaucomatous pharmaceutical compositions and the¹process for obtaining them
DZ920090A DZ1600A1 (fr) 1991-07-17 1992-07-12 Compositions pharmaceutiques anti-glaucomateurses et leur procédé d'obtention.
MA22876A MA22592A1 (fr) 1991-07-17 1992-07-13 Nouveau procede d'obtention d'une composition anti-glaucomateuse et son procede d'obtention .
TNSN92063 TNSN92063A1 (fr) 1991-07-17 1992-07-16 Nouveau procede d'obtention d'une composition anti- glaucomateuse et son procede d'obtention
GR990403060T GR3031967T3 (en) 1991-06-18 1999-11-26 Ocular compositions containing steroids and their use in treating glaucoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109017A FR2679139B1 (fr) 1991-07-17 1991-07-17 Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.

Publications (2)

Publication Number Publication Date
FR2679139A1 FR2679139A1 (fr) 1993-01-22
FR2679139B1 true FR2679139B1 (fr) 1995-03-17

Family

ID=9415213

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9109017A Expired - Fee Related FR2679139B1 (fr) 1991-06-18 1991-07-17 Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.

Country Status (1)

Country Link
FR (1) FR2679139B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617299A (en) * 1983-12-19 1986-10-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4812448A (en) * 1984-10-22 1989-03-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4863912A (en) * 1986-05-19 1989-09-05 New York Medical College Use of tetrahydrocortisol in glaucoma therapy

Also Published As

Publication number Publication date
FR2679139A1 (fr) 1993-01-22

Similar Documents

Publication Publication Date Title
MA22521A1 (fr) Compositions anti- transpirantes en batonnets-gels contenant un derive de la 2-oxazolidinone, et procede pour leur preparation
MA22522A1 (fr) Procede de formulation de compositions pharmaceutiques
MA26438A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26410A1 (fr) Formulations pharmaceutiques et procede pour leur production.
FR2555584B1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
ATE121295T1 (de) Augentropfenarzneimittel.
FR2689508B1 (fr) Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.
FR2668148B1 (fr) Nouveau derive de 5h-benzodiazepine, compositions pharmaceutiques le contenant et procede pour les preparer.
FR2662692B1 (fr) Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
FR2700956B1 (fr) Composition cosmetique et pharmaceutique et procede pour sa preparation.
FR2657872B2 (fr) Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
FR2675144B1 (fr) Nouvelles quinolones difluorees - leur procede de preparation et les compositions pharmaceutiques en renfermant.
FR2679139B1 (fr) Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.
MA22611A1 (fr) Derives d'ammonium quaternaire de (+) et (-) 10-(1-azabicyclo(2,2,2) oct-3-yl-methyl) -10-h-pheno-thiazine, compositions pharmaceutiques les contenant et procede pour leur preparation .
FR2676926B1 (fr) Compositions pharmaceutiques a base de polydesoxyribonucleotides et leur procede de preparation.
FI942675A0 (fi) Uudet substituoidut oksatsinoisokinoliinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi
HUT60737A (en) Process for producing new 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient
FR2643081B1 (fr) Folates de magnesium, procede de preparation et compositions pharmaceutiques
IL100393A0 (en) 15-nitro-2beta,3beta-dihydro-and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives,their preparation and pharmaceutical compositions containing them
FR2679137B1 (fr) Nouvelles compositions pharmaceutiques a base d'un derive pregnenique et leur procede de preparation.
FR2674247B1 (fr) Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
HU9203326D0 (en) Method for producing 1,5-benzo-thiazepinone derivatives and pharmaceutical preparatives containing them
FR2692577B1 (fr) Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2649981B1 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse